More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$238630824
EPS
-1.69
P/E ratio
--
Price to sales
0.98
Dividend yield
--
Beta
1.606354
Previous close
$2.30
Today's open
$2.27
Day's range
$2.24 - $2.32
52 week range
$2.15 - $5.68
CEO
Kevin Coop
Employees
782
Headquarters
Framingham, MA
Exchange
Nasdaq Global Select
Shares outstanding
103303387
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Definitive Healthcare Corp. (DH) Q3 2025 Earnings Call Transcript
Definitive Healthcare Corp. ( DH ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Jonathan Paris - Chief Legal Officer & Secretary Kevin Coop - CEO & Director Casey Heller - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Nishad Patwardhan - Goldman Sachs Group, Inc., Research Division Johnathan McCary - Raymond James & Associates, Inc., Research Division Jenny Shen - BTIG, LLC, Research Division David Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Welcome to Definitive Healthcare's Q3 2025 Earnings Call.
Seeking Alpha • Nov 7, 2025

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2025
FRAMINGHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2025.
GlobeNewsWire • Nov 6, 2025

Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.1 per share a year ago.
Zacks Investment Research • Nov 7, 2025

Definitive Healthcare Announces Timing of Its Third Quarter 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
GlobeNewsWire • Oct 23, 2025

Forum Ventures Bets Big on Category-Defining Vertical AI Solution for Healthcare Growth, Salubrum
New York City, NY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Salubrum, a vertical artificial intelligence (AI) company, has launched a category-defining commercialization engine for healthcare growth. In an industry where legacy agencies struggle to scale, Salubrum's AI-first approach productizes and automates the traditional marketing agency. Salubrum has partnered with industry giant Definitive Healthcare (NASDAQ: DH) to provide best-in-class precision patient activation, reimagining how healthcare brands go to market.
GlobeNewsWire • Oct 17, 2025

What Makes Definitive Healthcare (DH) a New Buy Stock
Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research • Oct 13, 2025

Definitive Healthcare Corp. (DH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Definitive Healthcare Corp. (NASDAQ:DH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 9:15 AM EDT Company Participants Kevin Coop - CEO & Director Casey Heller - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Presentation Craig Hettenbach VP & Equity Analyst All right. Great. Well, good morning, everyone.
Seeking Alpha • Sep 9, 2025

Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
FRAMINGHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and Chief Financial Officer, Casey Heller, will present at the Morgan Stanley 23rd Annual Global Healthcare Conference.
GlobeNewsWire • Sep 2, 2025

DH vs. BL: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Internet - Software sector have probably already heard of Definitive Healthcare Corp. (DH) and BlackLine (BL). But which of these two stocks offers value investors a better bang for their buck right now?
Zacks Investment Research • Aug 19, 2025

Definitive Healthcare Corp. (DH) Q2 2025 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Casey Heller - Chief Financial Officer Jonathan Paris - Chief Legal Officer Kevin D. Coop - CEO & Director Conference Call Participants David Michael Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division George Robert Hill - Deutsche Bank AG, Research Division Johnathan M.
Seeking Alpha • Aug 8, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Definitive Healthcare Corp. commission-free¹. Build wealth for the long term using automated trading and transfers.